Refine your search

    Advanced filters

    Refine your search further by applying these filters.
    Location
      Status
      Sex
      Age

      Advanced filters

      123 trials found for russia

      Recruiting
      Not yet recruiting
      Recruiting
      NCT05317416
      Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant

      Multiple Myeloma

      Male or Female
      18+ years
      224study location(s)
      1626.4 mi to closest study location
      Recruiting
      NCT06641466
      A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine

      Menstrual Migraine

      Females
      18 - 45 years
      34study location(s)
      1669.3 mi to closest study location
      Recruiting
      NCT04389632
      A Study of Sigvotatug Vedotin in Advanced Solid Tumors

      Carcinoma, Non-Small Cell Lung, Squamous Cell Carcinoma of Head and Neck, HER2 Negative Breast Neoplasms, Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Ovarian Neoplasms, Cutaneous

      Male or Female
      18+ years
      131study location(s)
      1889.9 mi to closest study location
      Recruiting
      NCT05911295
      Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2

      Urothelial Carcinoma

      Male or Female
      18+ years
      302study location(s)
      1889.9 mi to closest study location
      Recruiting
      NCT06157892
      A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors

      Breast Neoplasms, Gastroesophageal Junction Adenocarcinoma, HER2 Low Breast Neoplasms, HER2 Positive Breast Neoplasms, Stomach Neoplasms, Triple Negative Breast Neoplasms, Metastatic Breast Cancer, Metastatic Gastric Cancer, Advanced Breast

      Male or Female
      18+ years
      122study location(s)
      1889.9 mi to closest study location
      Recruiting
      NCT06152575
      MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

      Multiple Myeloma

      Male or Female
      18+ years
      206study location(s)
      1898.7 mi to closest study location
      Recruiting
      NCT06137742
      A Study to Learn About the Study Medicine Called PF-07868489 in Healthy Adult People and in People With Pulmonary Arterial Hypertension

      Pulmonary Arterial Hypertension

      Male or Female
      18 - 65 years
      14study location(s)
      1898.7 mi to closest study location
      Recruiting
      NCT05189639
      A Study To Learn About the Safety Medicine (Called Mylotarg) In People With Acute Myeloid Leukemia

      Acute Myeloid Leukemia

      Male or Female
      19+ years
      1study location(s)
      1898.7 mi to closest study location
      Recruiting
      NCT04876781
      Korean Post-marketing Surveillance for Xeljanz XR

      Active Moderate to Severe Rheumatoid Arthritis, Active Ankylosing Spondylitis, Active Psoriatic Arthritis

      Male or Female
      18+ years
      1study location(s)
      1898.7 mi to closest study location
      Recruiting
      NCT05623020
      A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135), Daratumumab, Lenalidomide or Elranatamab and Lenalidomide Compared With Daratumumab, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant

      Multiple Myeloma

      Male or Female
      18+ years
      65study location(s)
      1898.7 mi to closest study location

      Saved trials

      Saved trials

      You currently don’t have any saved trials. To save a trial, select the bookmark icon on the result listing.

      Recruiting
      Not yet recruiting

      Contact us

      For more information about participation in a Pfizer clinical trial, please email or call the Pfizer Clinical Trial Contact Center at 1-800-887-7002.